NIH Funding Opportunities (Notices, PA, RFA)
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 1 hour 26 min ago
Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-111 from the NIH Guide for Grants and Contracts. The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later-phase therapeutics discovery and development efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to obesity, diabetes and related aspects of endocrinology and metabolism, digestive diseases, liver diseases, nutrition, kidney and urological diseases, and hematology. Additional information concerning programmatic areas at NIDDK is available a www.niddk.nih.gov/research-funding/research-programs/Pages/default.aspx and applicants are strongly encouraged to discuss research priorities with the Scientific Contact.
Categories: Job Watch, Literature Watch
Notice of Intent to Publish a Funding Opportunity Announcement for Learning Disabilities Research Centers (P50 Clinical Trial Optional)
Notice NOT-HD-22-001 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NIAAA's Participation in PAR-21-358, Risk and Protective Factors of Family Health and Family Level Interventions (R01 - Clinical Trial Optional)
Notice NOT-AA-22-010 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction for PAR-22-091, "Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)"
Notice NOT-CA-22-049 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to RFA-CA-22-001, "Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)"
Notice NOT-CA-22-050 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Change to RFA-CA-22-003, "Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)"
Notice NOT-CA-22-051 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NCI Participation in PAR-22-064, "Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional)"
Notice NOT-CA-22-048 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of NINDS Participation in RFA-MD-22-004 "Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)".
Notice NOT-NS-22-067 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction for PAR-22-088 Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
Notice NOT-OD-22-072 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Correction for PAR-22-081 Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
Notice NOT-OD-22-070 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Addressing Cancer-Related Financial Hardship to Improve Patient Outcomes
Notice NOT-CA-22-045 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest (NOSI): Administrative Supplements for Advancing the Ethical Development and Use of AI/ML in Biomedical and Behavioral Sciences
Notice NOT-OD-22-065 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest: NIMH Priorities on Research on Aggression and Violence Against Others
Notice NOT-MH-22-095 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
Notice of Special Interest: Neuro-Glia Mechanisms Governing Complex Behaviors (R01 Clinical Trial Optional)
Notice NOT-MH-22-090 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIA Caenorhabditis Intervention Testing Program (CITP) Announces A Call for Compounds to Test for Anti-Aging Activity in Caenorhabditis
Notice NOT-AG-22-009 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U24 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-110 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) allows for renewal and competitive revision applications, and their resubmissions, for funded U24?Research Resource/Infrastructure?applications?that?support?large-scale, complex research programs focused on?Alzheimers disease (AD) and?Alzheimers disease-related dementias (ADRD).?It is anticipated that such programs will likely involve a team of investigators within a single institution or a consortium of?institutions?and?align with one or more?AD/ADRD implementation research milestones?supporting the?research goals of the??National Plan to Address Alzheimers and Related Dementias.
Categories: Job Watch, Literature Watch
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-101 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.
Categories: Job Watch, Literature Watch
Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R03 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-100 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics towards clinical trials, and to increase their likelihood of success through development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.
Categories: Job Watch, Literature Watch
Innovative Pilot Mental Health Services Research Not Involving Clinical Trials (R34 Clinical Trial Not Allowed)
Funding Opportunity PAR-22-082 from the NIH Guide for Grants and Contracts. Reissue of PAR-19-189. The purpose of this funding announcement is to encourage pilot research that is not an immediate precursor to testing a service intervention but is consistent with NIMH priorities for services research. While NIMH now requires use of an experimental therapeutics model for all intervention studies, there is recognition that some mission-relevant areas of services research do not involve clinical trials.
Categories: Job Watch, Literature Watch
Request for Information (RFI): Inviting Comments and Suggestions to Advance Research and Vaccine Development for Coccidioidomycosis (Valley Fever)
Notice NOT-AI-22-026 from the NIH Guide for Grants and Contracts
Categories: Job Watch, Literature Watch